Aura Biosciences Archives – Droia Ventures

05 Jan Aura Biosciences Appoints David Johnson to Its Board of Directors

Posted at 14:08h in Aura Biosciences

With David’s impressive track record in oncology and as an accomplished CEO, his engagement and guidance will help Aura drive AU-011 for the treatment of choroidal melanoma to registration and commercialization,” said George Golumbeski, Ph.D., Chairman of the Board of Aura Biosciences....

07 Jan Aura Biosciences Appoints George Golumbeski, Ph.D., as Chairman of the Board of Directors

Posted at 14:21h in Aura Biosciences

“George’s extensive experience will be invaluable to Aura as we prepare for upcoming corporate milestones,” said Elisabet de los Pinos, Ph.D., Chief Executive Officer of Aura Biosciences....

02 Apr Aura Biosciences Completes $40 Million Series D Financing

Posted at 14:28h in Aura Biosciences

The Company plans to use the proceeds from the Series D financing to support the late stage clinical development of their lead asset, light-activated AU-011, for the treatment of primary choroidal melanoma....